Clinical Trials
4 trialsNCT05976893 2023-08-04
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer
Xinjiang Medical University
Phase 4 Unknown
NCT03186404 2022-02-08
SPARE-HF
University Health Network, Toronto
Phase 2 Unknown
NCT03971019 2019-08-14
SBSBC
Peking Union Medical College Hospital
Phase 3 Unknown
NCT00914017 2010-02-11
Statins and Breast Cancer Biomarkers
University of Vermont
Phase 2 Unknown